| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ad0326688e21e36026b427d539d69f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_207df7a866be274cd89ea723e9efaf37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8eee133dfc0520b22df3c9fca50fd21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86e3f9618a91993ccbe28b6938a6de99 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dcdf311c640eed31088049b4165e7e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91e1cf4be0333dd58f83e89dffd9d132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8083ea1fd2e28fbb59d891ab6933243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f698f0eb1cc907b84504bde83d1dea |
| publicationDate |
2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005220777-A1 |
| titleOfInvention |
Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae |
| abstract |
A method of selection of lactic acid bacteria for providing a method of protecting humans against Streptococcus pneumoniae infections by selecting a lactic acid bacterial strain (LAB) naturally carrying genes coding for proteins similar to the PspC, choline binding protein of S. pneumoniae so that the selected LAB can be used in various products for oral and nasal administration to humans as immune enhancers against S. pneumoniae, and products containing specifically selected LAB that naturally carry genes coding for proteins similar to PcpC binding protein of S. pneumoniae as oral and nasal immune enhancers for humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009151391-A1 |
| priorityDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |